Terms: = Ovarian cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Diagnosis
31 results:
1. Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
Bychkovsky BL; Lo MT; Yussuf A; Horton C; Hemyari P; LaDuca H; Garber JE; Scheib R; Rana HQ
Breast Cancer Res Treat; 2023 Jul; 200(1):63-72. PubMed ID: 36856935
[TBL] [Abstract] [Full Text] [Related]
2. Interdisciplinary risk counseling for hereditary breast and ovarian cancer: real-world data from a specialized center.
Zang B; Helms M; Besch L; Kalmbach N; Stegen S; Blohmer JU; Speiser D
Arch Gynecol Obstet; 2023 May; 307(5):1585-1592. PubMed ID: 36307613
[TBL] [Abstract] [Full Text] [Related]
3. Familial and hereditary gastric cancer, an overview.
Carneiro F
Best Pract Res Clin Gastroenterol; 2022; 58-59():101800. PubMed ID: 35988963
[TBL] [Abstract] [Full Text] [Related]
4. Low BRCA1 and BRCA2 Germline Mutation Rates in a French-Canadian Population with a diagnosis of Epithelial Tubo-ovarian Carcinoma.
Bernard J; Mehros W; Gregoire J; Douville P; Renaud MC; Sebastianelli A; Langlais EL; Plante M
J Obstet Gynaecol Can; 2022 Oct; 44(10):1047-1053. PubMed ID: 35779836
[TBL] [Abstract] [Full Text] [Related]
5. Gene Sequencing for Pathogenic Variants Among Adults With Breast and ovarian cancer in the Caribbean.
George SHL; Donenberg T; Alexis C; DeGennaro V; Dyer H; Yin S; Ali J; Butler R; Chin SN; Curling D; Lowe D; Lunn J; Turnquest T; Wharfe G; Cerbon D; Barreto-Coelho P; Schlumbrecht MP; Akbari MR; Narod SA; Hurley JE
JAMA Netw Open; 2021 Mar; 4(3):e210307. PubMed ID: 33646313
[TBL] [Abstract] [Full Text] [Related]
6. The Relationship of FOXR2 Gene Expression Profile with Epithelial-Mesenchymal Transition Related Markers in Epithelial ovarian cancer.
Asadollahi S; Mazaheri MN; Karimi-Zarchi M; Fesahat ; Farzaneh
Klin Onkol; 2020; 33(3):201-207. PubMed ID: 32683876
[TBL] [Abstract] [Full Text] [Related]
7. Genetic Testing and Screening Recommendations for Patients with Hereditary Breast cancer.
Bharucha PP; Chiu KE; François FM; Scott JL; Khorjekar GR; Tirada NP
Radiographics; 2020; 40(4):913-936. PubMed ID: 32469631
[TBL] [Abstract] [Full Text] [Related]
8. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
da Costa E Silva Carvalho S; Cury NM; Brotto DB; de Araujo LF; Rosa RCA; Texeira LA; Plaça JR; Marques AA; Peronni KC; Ruy PC; Molfetta GA; Moriguti JC; Carraro DM; Palmero EI; Ashton-Prolla P; de Faria Ferraz VE; Silva WA
BMC Med Genomics; 2020 Feb; 13(1):21. PubMed ID: 32039725
[TBL] [Abstract] [Full Text] [Related]
9. [Borderline ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiological Aspects and Risk Factors].
Ouldamer L; Body G; Daraï E; Bendifallah S
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):239-247. PubMed ID: 32004787
[TBL] [Abstract] [Full Text] [Related]
10. Association of the Affordable Care Act With ovarian cancer Care.
Smith AJB; Fader AN
Obstet Gynecol; 2020 Feb; 135(2):257-265. PubMed ID: 31923060
[TBL] [Abstract] [Full Text] [Related]
11. Aberrant Methylation Status of Tumour Suppressor Genes in ovarian cancer Tissue and Paired Plasma Samples.
Dvorská D; Braný D; Nagy B; Grendár M; Poka R; Soltész B; Jagelková M; Zelinová K; Lasabová Z; Zubor P; Danková Z
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450846
[TBL] [Abstract] [Full Text] [Related]
12. Impact of Timeliness of Surgical Treatment on the Outcomes of Patients with Non-metastatic Non-small Cell Lung cancer: Findings From the PLCO Trial.
Abdel-Rahman O
World J Surg; 2019 Nov; 43(11):2927-2933. PubMed ID: 31332492
[TBL] [Abstract] [Full Text] [Related]
13. [The French Genetic and cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition].
Moretta J; Berthet P; Bonadona V; Caron O; Cohen-Haguenauer O; Colas C; Corsini C; Cusin V; De Pauw A; Delnatte C; Dussart S; Jamain C; Longy M; Luporsi E; Maugard C; Nguyen TD; Pujol P; Vaur D; Andrieu N; Lasset C; Noguès C;
Bull Cancer; 2018 Oct; 105(10):907-917. PubMed ID: 30268633
[TBL] [Abstract] [Full Text] [Related]
14. Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and ovarian cancer.
Hauke J; Horvath J; Groß E; Gehrig A; Honisch E; Hackmann K; Schmidt G; Arnold N; Faust U; Sutter C; Hentschel J; Wang-Gohrke S; Smogavec M; Weber BHF; Weber-Lassalle N; Weber-Lassalle K; Borde J; Ernst C; Altmüller J; Volk AE; Thiele H; Hübbel V; Nürnberg P; Keupp K; Versmold B; Pohl E; Kubisch C; Grill S; Paul V; Herold N; Lichey N; Rhiem K; Ditsch N; Ruckert C; Wappenschmidt B; Auber B; Rump A; Niederacher D; Haaf T; Ramser J; Dworniczak B; Engel C; Meindl A; Schmutzler RK; Hahnen E
Cancer Med; 2018 Apr; 7(4):1349-1358. PubMed ID: 29522266
[TBL] [Abstract] [Full Text] [Related]
15. Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
Harter P; Hauke J; Heitz F; Reuss A; Kommoss S; Marmé F; Heimbach A; Prieske K; Richters L; Burges A; Neidhardt G; de Gregorio N; El-Balat A; Hilpert F; Meier W; Kimmig R; Kast K; Sehouli J; Baumann K; Jackisch C; Park-Simon TW; Hanker L; Kröber S; Pfisterer J; Gevensleben H; Schnelzer A; Dietrich D; Neunhöffer T; Krockenberger M; Brucker SY; Nürnberg P; Thiele H; Altmüller J; Lamla J; Elser G; du Bois A; Hahnen E; Schmutzler R
PLoS One; 2017; 12(10):e0186043. PubMed ID: 29053726
[TBL] [Abstract] [Full Text] [Related]
16. Associations Between cancer Predisposition Testing Panel Genes and Breast cancer.
Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS
JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444
[TBL] [Abstract] [Full Text] [Related]
17. Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells.
Ahmed N; Greening D; Samardzija C; Escalona RM; Chen M; Findlay JK; Kannourakis G
Sci Rep; 2016 Jul; 6():30061. PubMed ID: 27470985
[TBL] [Abstract] [Full Text] [Related]
18. Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.
Castéra L; Krieger S; Rousselin A; Legros A; Baumann JJ; Bruet O; Brault B; Fouillet R; Goardon N; Letac O; Baert-Desurmont S; Tinat J; Bera O; Dugast C; Berthet P; Polycarpe F; Layet V; Hardouin A; Frébourg T; Vaur D
Eur J Hum Genet; 2014 Nov; 22(11):1305-13. PubMed ID: 24549055
[TBL] [Abstract] [Full Text] [Related]
19. A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA.
Zhang Q; Hu G; Yang Q; Dong R; Xie X; Ma D; Shen K; Kong B
Gynecol Oncol; 2013 Jul; 130(1):132-9. PubMed ID: 23623832
[TBL] [Abstract] [Full Text] [Related]
20. History of cholelithiasis and cancer risk in a network of case-control studies.
Tavani A; Rosato V; Di Palma F; Bosetti C; Talamini R; Dal Maso L; Zucchetto A; Levi F; Montella M; Negri E; Franceschi S; La Vecchia C
Ann Oncol; 2012 Aug; 23(8):2173-2178. PubMed ID: 22231026
[TBL] [Abstract] [Full Text] [Related]
[Next]
